Specific Clinical Experience Investigation for Long-term Use of Bydureon Subcutaneous Injection 2 mg

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by AstraZeneca
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01940770
First received: September 9, 2013
Last updated: April 13, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2020
  Estimated Primary Completion Date: April 2020 (Final data collection date for primary outcome measure)